Journal: Diabetes/metabolism research and reviews

Article Title: Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes.

PMID/MRN: 27667744

Publication Date: 2016-Sep-26

Abstract:

Carboxylated osteocalcin (Gla-OC) participates in bone remodeling, whereas the undercarboxylated form (Glu-OC) takes part in energy metabolism. This study was undertaken to compare the blood levels of Glu-OC and Gla-OC in non-obese, healthy obese as well as prediabetic volunteers and correlate it with the metabolic markers of insulin resistance and early markers of inflammation. Non-obese (BMI <30 kg/m 2 , n = 34) and obese subjects (>30 BMI <40 kg/m 2 , n = 98), both sexes, aged 25-65 years were divided into: healthy control, normal weight subjects, healthy obese and obese with biochemical markers of prediabetes and subgroups with obesity and low or high Gla-OC or Glu-OC and considered for statistical analysis. After two weeks of diet standardization venous blood was sampled for determination of Gla-OC, Glu-OC, lipid profile, parameters of inflammation (hsCRP, IL-6, sE-selectin, sPECAM-1, MCP-1) and adipokines (leptin, adiponectin, visfatin, resistin). Gla-OC in obese patients was significantly lower compared to non-obese ones (11.36 ± 0.39 vs 12.69 ± 0.90 ng/ml, P=0.048) and weakly correlated with: hsCRP (r = -0.18, P = 0.042), visfatin concentration (r=-0.19, P=0.033) and BMI (r=-0.17, P=0.047). Glu-OC was negatively associated with fasting insulin levels (r=-0.18, P=0.049) and reduced in prediabetic individuals compared to healthy obese volunteers (3.04 ± 0.28 vs 4.48 ± 0.57, P=0.025). Decreased blood concentration of Glu-OC may be a selective early symptom of insulin resistance development in obesity, whereas the decreased level of Gla-OC seems to be associated with the appearance of early markers of low grade inflammation accompanying obesity. This article is protected by copyright. All rights reserved.